Publication

Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.

Saito S, Nakazawa Y, Sueki A, Matsuda K, Tanaka M, Yanagisawa R, Maeda Y, Sato Y, Okabe S, Inukai T, Sugita K, Wilson MH, Rooney CM, Koike K
Cytotherapy. 2014 16 (9): 1257-69

PMID: 25108652 · PMCID: PMC4948190 · DOI:10.1016/j.jcyt.2014.05.022

MeSH Terms (22)

Antigens, CD19 Cancer Vaccines Cell Line, Tumor Cell Proliferation Culture Media, Serum-Free Cytotoxicity, Immunologic DNA Transposable Elements Drug Resistance, Neoplasm Genetic Engineering Genetic Vectors Humans Immunotherapy, Adoptive Interleukin-2 Interleukin-15 Leukemia, Myelogenous, Chronic, BCR-ABL Positive Mutation Protein Kinase Inhibitors Receptors, Antigen, T-Cell Recombinant Fusion Proteins T-Lymphocytes TNF-Related Apoptosis-Inducing Ligand Up-Regulation

Connections (1)

This publication is referenced by other Labnodes entities:

Links